Die Grafik zeigt die prognostizierten Quartalsgewinne (Bereinigter Gewinn pro Aktie, EPS) und die tatsächlich erzielten Gewinne (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Umsatz (USD)
Schätzung
Umsatz
Die Grafik zeigt die prognostizierten Quartalsumsätze und die tatsächlich erzielten Umsätze (grün: Analystenschätzungen übertroffen, rot: Analystenschätzungen verfehlt) für den ausgewählten Zeitraum.
Güte der Analystenschätzungen – EPS (aktueller Zeitraum)
Quartal / Datum
EPS (USD)
Schätzung (USD)
Abweichung
Quartal / Datum
Umsatz (Mio USD)
Schätzung (Mio USD)
Abweichung
Revisionen der Gewinnschätzungen
EPS-Schätzungen für die Geschäftsjahre
2025, 2026, 2027.
PARAMUS, N.J., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it has restructured the $300 million mortgage loan on the retail condominium of 731 Lexington Avenue in Manhattan. Under the terms of the restructuring, the existing loan was split into a $132.5 million senior “A-Note” accruing current interest at 7.00% per annum and a $167.5 million junior “C-Note” accruing interest at 4.55% per annum, with a new maturity date of December 23, 2035.
Alexander's, Inc. (NYSE: ALX - Get Free Report) saw unusually-high trading volume on Friday. Approximately 44,573 shares were traded during trading, an increase of 1% from the previous session's volume of 44,283 shares.The stock last traded at $217.3350 and had previously closed at $218.16. Analysts Set New Price Targets A number of brokerages have recently
Alexander's, Inc. (NYSE: ALX - Get Free Report) shares saw an uptick in trading volume on Friday. 54,369 shares traded hands during trading, an increase of 25% from the previous session's volume of 43,607 shares.The stock last traded at $217.48 and had previously closed at $218.56. Analysts Set New Price Targets ALX has been the
Alexander's, Inc. is a commercial REIT managing five properties in New York, with Bloomberg accounting for 60% of revenues. ALX's Q3 2025 results show FFO growth of 2.5%, principally driven by lower funding costs, which more than offset a drop in net operating income. Looking ahead to Q4 2025 and 2026, I see ALX's net operating income returning to growth thanks to recent occupancy gains.
Shares of Alexander's, Inc. (NYSE: ALX - Get Free Report) passed below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $229.44 and traded as low as $214.80. Alexander's shares last traded at $215.8270, with a volume of 80,019 shares traded. Wall Street Analyst Weigh In A number
PARAMUS, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it has completed a $175 million refinancing of its 615,000 square foot Rego Park II shopping center located in Queens, New York. The interest-only loan is at SOFR plus 2.00%, currently 5.82%, and matures in December 2030.
SOUTH SAN FRANCISCO, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or the "Company") (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, today announced that ALX Oncology leadership will participate in both the Jefferies Global Healthcare Conference in London and Piper Sandler 37th Annual Global Healthcare Conference in New York.